Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A model for the hepatitis C virus envelope glycoprotein E2.

A T Yagnik1, A Lahm, A Meola

  • 1Istituto di Ricerche di Biologia Molecolare P. Angeletti, Pomezia (Rome), Italy.

Proteins
|June 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soil loss tolerance in the context of the European Green Deal.

Heliyon·2023
Same author

Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper.

International journal of cardiology·2022
Same author

Weight loss effect of liraglutide in real-life: the experience of a single Italian obesity center.

Journal of endocrinological investigation·2020
Same author

Varying development of femoral and tibial subchondral bone tissue and their interaction with articular cartilage during progressing osteoarthritis.

Archives of orthopaedic and trauma surgery·2020
Same author

Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia.

Journal of perinatology : official journal of the California Perinatal Association·2020
Same author

Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism.

Journal of endocrinological investigation·2018

Developing a hepatitis C virus (HCV) E2 protein model using fold recognition aids vaccine development. This model predicts interactions with CD81 and heparin, crucial for understanding HCV entry.

Area of Science:

  • Structural biology
  • Virology
  • Vaccine development

Background:

  • Hepatitis C virus (HCV) envelope glycoprotein E2 is a key target for vaccine development.
  • Understanding HCV E2 structure is critical for designing effective vaccines.

Purpose of the Study:

  • To generate a structural model of the HCV E2 protein using fold recognition methods.
  • To predict interaction sites between HCV E2 and its cellular receptor CD81, and identify a heparin binding domain.

Main Methods:

  • Application of fold recognition methods to model HCV E2.
  • Utilizing Tick Borne Encephalitis virus E protein as a structural template.
  • Mapping experimental data onto the generated structural model.

Main Results:

Related Experiment Videos

  • A structural model for HCV E2 was successfully produced.
  • A composite interaction site for E2 and CD81, and a heparin binding domain were predicted.
  • CD81 recognition by E2 was found to be isolate/strain specific, potentially involving the HVR2 region.
  • A preliminary model of the E1-E2 glycoprotein complex quaternary structure was proposed.

Conclusions:

  • The structural model of HCV E2 provides insights into its function and interactions.
  • The findings contribute to the rational design of HCV vaccines targeting E2.
  • Further research into E2-CD81 interactions and the role of HVR2 is warranted.